Evidence-based Complementary and Alternative Medicine · 2015 · 21 citations · 37 references
Veterinary MedicineImmunologyPharmacologyImmunopathologyInflammationInnate ImmunityBiomarkers Of Liver InjuryHepatic PathophysiologyInflammatory SignalingLiver DiseaseLiver Function TestsMetabolic InflammationAspartate Aminotransferase ElevationOxidative BiomarkersOxidative Stress BiomarkersOxidative Stress In Liver InjuryProinflammatory MediatorsSerum Alanine AminotransferaseSerum Aspartate AminotransferaseTraditional Chinese Medicine
Ethnopharmacological Relevance. The Hugan Qingzhi tablet (HQT) is a traditional Chinese medicine used for treating NAFLD (nonalcoholic fatty liver disease). The present study evaluated the anti-inflammatory effects of HQT in rats with NAFLD. Materials and Methods. HQT was administered daily to the NAFLD experimental groups. Biochemical markers, histopathological data, and oxidative stress/antioxidant biomarkers were determined. Proinflammatory cytokines interleukin-1β (IL-1β), tumor necrosis factor α (TNF-α), and interleukin-6 (IL-6) were detected by enzyme-linked immunoassay. Expressions of silent information regulator 1 (SIRT1) and acetylated-nuclear-factor kappaB-p65 (Ac-NF-κB-p65) were performed by western blotting. Results. At high and moderate doses, HQT was highly effective in decreasing serum alanine aminotransferase (P < 0.01), aspartate aminotransferase (P < 0.01), hepatic total cholesterol (P < 0.01), triglycerides (P < 0.01), and free fatty acid levels (P < 0.01). Moreover, high and moderate doses of HQT reduced hepatic levels of the proinflammatory cytokines TNF-α (P < 0.01), IL-1β (P < 0.01), and IL-6 (P < 0.01), enhanced SIRT1 expression, and depressed Ac-NF-κB-p65 expression at protein level. Conclusions. In our NAFLD rat model, HQT exerted substantial anti-inflammatory and antioxidant activities, possibly involving the regulation of SIRT1 and Ac-NF-κB-p65 expression.
37
Design and validation of a histological scoring system for nonalcoholic fatty liver disease†
David E. Kleiner, Elizabeth M. Brunt, Mark L. Van Natta et al. · Hepatology · 2005 · 10.7K citations
Modulation of NF‐κB‐dependent transcription and cell survival by the SIRT1 deacetylase
Fan Yeung, Jamie E. Hoberg, C S Ramsey et al. · The EMBO Journal · 2004 · 2.7K citations · Full text
Sirt1 promotes fat mobilization in white adipocytes by repressing PPAR-γ
Frédéric Picard, Martin V. Kurtev, Acharawan Topark‐Ngarm et al. · Nature · 2004 · 1.9K citations · Full text